Prognostic factors in metastatic germ-cell cancer

被引：6

作者：

Beyer, J. ^{[1
]}

机构：

[1] Univ Bern, Bern Univ Hosp, Inselspital, Dept Med Oncol, Freiburgstr, CH-3010 Bern, Switzerland

来源：

ANDROLOGY | 2019年 / 7卷 / 04期

关键词：

classification; germ-cell cancer; prognosis; staging; treatment; TUMOR-MARKER DECLINE; MULTIVARIATE-ANALYSIS; CHEMOTHERAPY; CISPLATIN; DIAGNOSIS; BLEOMYCIN; CONSENSUS; SURVIVAL;

D O I：

10.1111/andr.12615

中图分类号：

R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

摘要：

Determining stage and anticipating prognosis are the two crucial steps after the diagnosis of a germ-cell cancer that both guide subsequent treatment decisions. This review focuses on metastatic disease, which means germ-cell cancers beyond stage I limited to the testis. In the past, major centers developed separate staging and prognostic classifications for metastatic germ-cell cancer, which heavily impaired communication and comparisons across clinical trials. More recently, the classification system of the International Germ-Cell Cancer Collaborative Group (IGCCCG) has found acceptance worldwide and is currently being updated.

引用

页码：475 / 478

页数：4

共 29 条

[1] Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014aEuro [J].

Adra, N. ;

Althouse, S. K. ;

Liu, H. ;

Brames, M. J. ;

Hanna, N. H. ;

Einhorn, L. H. ;

Albany, C. .

ANNALS OF ONCOLOGY, 2016, 27 (05) :875-879

[2]

[Anonymous], 1997, J Clin Oncol, V15, P594

[3]

[Anonymous], EUR UROL

[4]

[Anonymous], J NAT CANC I

[5] Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy [J].

Beyer, Joerg ;

Lorch, Anja ;

Beyer, Joerg ;

Bascoul-Mollevi, C. ;

Kramar, A. ;

Einhorn, Lawrence H. ;

Necchi, A. ;

Massard, C. ;

De Giorgi, U. ;

Flechon, A. ;

Margolin, Kim A. ;

Lotz, Jean-Pierre ;

Lluch, Jose Ramon Germa ;

Powles, Thomas ;

Kollmannsberger, Christian K. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) :4906-4911

[6]

Bierley JD., 2017, TNM classification of malignant tumors, V8th, DOI DOI 10.1002/EJOC.201200111

[7] PROGNOSTIC FACTORS FOR FAVORABLE OUTCOME IN DISSEMINATED GERM-CELL TUMORS [J].

BIRCH, R ;

WILLIAMS, S ;

CONE, A ;

EINHORN, L ;

ROARK, P ;

TURNER, S ;

GRECO, FA .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :400-407

[8] Extragonadal germ cell tumors of the mediastinum and retroperitoneum: Results from an international analysis [J].

Bokemeyer, C ;

Nichols, CR ;

Droz, JP ;

Schmoll, HJ ;

Horwich, A ;

Gerl, A ;

Fossa, SD ;

Beyer, J ;

Pont, J ;

Kanz, L ;

Einhorn, L ;

Hartmann, JT .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1864-1873

[9]

BOSL GJ, 1983, CANCER RES, V43, P3403

[10] REPORT ON THE INTERNATIONAL WORKSHOP ON STAGING AND TREATMENT OF TESTICULAR CANCER [J].

CAVALLI, F ;

MONFARDINI, S ;

PIZZOCARO, G .

EUROPEAN JOURNAL OF CANCER, 1980, 16 (10) :1367-1372

← 1 2 3 →